RNS Announcements

PDMR Shareholding

09 June 2025

ProBiotix Health plc (AQSE: PBX), the life sciences business developing probiotics to support cardiometabolic health, is pleased to announce that a PDMR of the Company has acquired 67,500 ordinary shares of 0.05p each in the Company ("Ordinary Shares") as  set out in the table below.

 

For further information, please contact:

 

ProBiotix Health plc

https://probiotixhealth-ir.com

Steen Andersen, Chief Executive Officer

Miles Nolan, Investor Relations

[email protected] 



Peterhouse Capital Limited

Aquis Corporate Adviser and Broker

 

 

Mark Anwyl

Duncan Vasey

Tel: 020 7220 9793

 

Notification and public disclosure of transactions by persons discharging managerial responsibilities and persons closely associated with them.

1

Details of the person discharging managerial responsibilities / person closely associated

a)

Name

Michael Litichevski

2

Reason for the notification

a)

Position/status

Vice President, Sales

b)

Initial notification /Amendment

 

Initial

3

Details of the issuer, emission allowance market participant, auction platform, auctioneer, or auction monitor

a)

Name

ProBiotix Health plc

b)

LEI

98450048683CF0388C30

4

Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted

a)

Description of the financial instrument, type of instrument

Identification code

ordinary shares of 0.05p each

ISIN: GB00BLNBFR86

b)

Nature of the transaction

Acquisition of ordinary shares

c)

Price(s) and volume(s)

67,500 ordinary shares @ 7.7p per share

d)

Aggregated information

- Aggregated volume

- Price

 

n/a - single transaction

e)

Date of the transaction

9 June 2025

f)

Place of the transaction

Aquis Growth Market

 

This announcement contains information which, prior to its disclosure, was considered inside information for the purposes of the UK Market Abuse Regulation and the Directors of the Company are responsible for the release of this announcement.

back to RNS & Investor News